Global /China /Healthcare /Drug Manufacturers - Specialty & Generic /002603

Shijiazhuang Yiling Pharmaceutical Co., Ltd.

002603

• SHE: 002603 • Delayed

17.04CNY 0.4%

2.52 USD

As of 8 June 2026, Shijiazhuang Yiling Pharmaceutical Co., Ltd. has a market cap of $4.2B USD, ranking #4293 globally and #859 in China. It ranks #325 in the Healthcare sector, and #10 in the Drug Manufacturers - Specialty & Generic industry.

Global Rank

4293

Country Rank

859

Sector Rank

325

Industry Rank

Key Stats

Market Cap

$4.2BUSD

28.47B CNY

Enterprise Value

$3.85BUSD

26.06B CNY

Revenue (TTM)

$1.17BUSD

7.91B CNY

EBITDA (TTM)

$339.14MUSD

2.3B CNY

Net Income (TTM)

$202.08MUSD

1.37B CNY

EBITDA Margin

29%

Profit Margin

17%

PE Ratio

20.8

Forward PE

19.3

PS Ratio

3.6

PB Ratio

2.5

EV/EBITDA

11.3

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Xiang Jun Wu open_in_new

Employees

11,708

Founded

1992

Website

yiling.cn open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0.4%	2.9%	2.8%	-7.5%	-4.1%	-0.6%	29%	-46%	-13%

News

Markets

Exchange	Ticker	Price	Quotes
Shenzhen Stock Exchange (SHE / SZSE) MIC: XSHE PRIMARY	002603 石家庄以岭药业股份有限公司 Class A ISIN: CNE1000015S0 Shares Out.: Shares Outstanding: 1.671B¹ Shares Float: 1.67B² TV: TradingView: SZSE: 002603 SA: Stock Analysis: SHE: 002603 YF: Yahoo Finance: 002603.SZ GF: Google Finance: SHE: 002603 BA: Barron's: 002603 MS: Morningstar: XSHE: 002603	17.04 CNY	TV: TradingView: SZSE: 002603 SA: Stock Analysis: SHE: 002603 YF: Yahoo Finance: 002603.SZ GF: Google Finance: SHE: 002603 BA: Barron's: 002603 MS: Morningstar: XSHE: 002603

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Shijiazhuang Yiling Pharmaceutical Co., Ltd.

Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese medicine primarily in China. It offers drugs for cardiovascular and cerebrovascular, respiratory, endocrine, neurological, digestive, immune, and urinary diseases, diabetes mellitus, oncology, sleep-improving, and anti-aging. The company also provides dietary supplements, disinfection products, personal protective equipment, as well as formula granules. Shijiazhuang Yiling Pharmaceutical Co., Ltd. was founded in 1992 and is based in Shijiazhuang, China.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (China)

Name	Market Cap (USD) diff.	PE	Country
Zhejiang NHU Company Ltd. SHE: 002001	$15.84B 107.34B CNY 277%	16.0	China
Haisco Pharmaceutical Group Co., Ltd. SHE: 002653	$9.09B 61.6B CNY 116%	80.6	China
Dong-E-E-Jiao Co., Ltd. SHE: 000423	$5.21B 35.33B CNY 24%	20.0	China
Jilin Aodong Pharmaceutical Group Co., Ltd. SHE: 000623	$3.26B 22.12B CNY -22%	8.1	China
China Resources Double-Crane Pharmaceutical Co.,Ltd. SSE: 600062	$2.74B 18.55B CNY -35%	11.5	China
Byhealth Co., Ltd. SHE: 300146	$2.61B 17.67B CNY -38%	24.0	China

Industry: Drug Manufacturers - Specialty & Generic (Global)

Name	Market Cap (USD) diff.	PE	Country
Teva Pharmaceutical Industries Ltd. TLV: TEVA	$37.66B 108.92B ILS 796%	24.2	Israel
Revolution Medicines, Inc. NASDAQ: RVMD	$29.56B 604%	-	United States
Cipla Ltd. NSE: CIPLA	$11.16B 1.06T INR 166%	23.4	India
Lupin Ltd. NSE: LUPIN	$11.04B 1.05T INR 163%	22.7	India
ABIVAX Société Anonyme EPA: ABVX	$8.79B 7.57B EUR 109%	-	France
Aurobindo Pharma Ltd. NSE: AUROPHARMA	$8.46B 807.02B INR 101%	23.1	India

chevron_leftBack